Health Care Technology
Company Overview of Nanthealth, LLC
NANTHEALTH, LLC, a transformational healthcare information technology company, provides cloud-based intelligent clinical operating systems for physicians, patients, payers, and researchers. It offers eviti|Advisor, a clinical decision support for oncologists; eviti|Advisor enterprise edition that enables identification of practice-preferred regimens for use by various providers in the practice, as well as facilitates identification of available clinical trials at the practice sites; and eviti|Connect, a Web-based platform that reduces the administrative time and tasks associated with obtaining preauthorization. The company also provides connectivity solutions, including DeviceConX (iSirona),...
9920 Jefferson Boulevard
Culver City, CA 90232
Founded in 2007
Key Executives for Nanthealth, LLC
Founder, Chairman and Chief Executive Officer
Senior Vice President of Strategy
Senior Vice President of Product Development
Compensation as of Fiscal Year 2014.
Nanthealth, LLC Key Developments
Toumaz Limited Agrees with NantHealth LLC to Terminate its North American Distribution Agreement for its SensiumVitals® Wireless Vital Signs Monitoring System
Mar 3 15
Toumaz Limited has agreed with NantHealth LLC to terminate its North American distribution agreement for its SensiumVitals® wireless vital signs monitoring system. This change, instigated by the Group, will allow Toumaz to address the key US market in a substantially more focused manner. The North American distribution rights for SensiumVitals® revert to Toumaz with immediate effect, in return for an undisclosed payment which will have a minimal impact on the Group's overall cash position. The region accounts for c.50% of the potential $1.5 billion global market for hospital-based wireless monitoring. The Group will position a small business development team in the US to support existing customers, follow through on leads generated by NantHealth LLC, introduce SensiumVitals® to the larger hospital groups and evaluate Toumaz's options for an accelerated deployment in the US. The Group will provide a further update on its strategy later this year. In Rest of World territories, interest in the system continues to build. SensiumVitals® has been deployed in hospitals in the UK, France, Italy, Germany, Portugal, and Australia - as well as the US. A growing number of these deployments are moving from initial evaluation to full-scale integration with hospital IT systems. Worldwide, the Group has a qualified pipeline of 200 hospitals.
NantHealth and Allscripts Join to Develop Precision Solutions
Mar 2 15
NantHealth and Allscripts will collaborate on the development and delivery of cutting-edge, precision medicine solutions directly to the point of care. The companies will introduce an integrated, evidence-based, personalized approach to healthcare solutions that includes actionable clinical data, enabling physicians to make informed decisions from complex genomic and proteomic analysis.
NantHealth Appoints Gary Palmer as Chief Medical Officer
Jan 16 15
NantHealth announced the appointment of Gary Palmer to the newly created position of chief medical officer (CMO), effective immediately. Palmer previously served as senior vice president, Medical Affairs, at Foundation Medicine, where he helped launch the FoundationOne assay.
Similar Private Companies By Industry
Recent Private Companies Transactions
February 6, 2015
June 18, 2014
June 5, 2014